LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced today financial results for the three months ended December 31, 2008. The Company reported a net loss of $459,000, or $0.01 per basic share, compared to a loss of $641,000, or $0.02 per basic share, for the three months ended December 31, 2007, a decrease of 28%.
